Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 2;17:11782234231167655. doi: 10.1177/11782234231167655

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Overview of the cohort. Upper heat map showing the TP53 signature. Lower panel shows the TP53 signature status, clinicopathological factors (tumor size, nodal status, ER, PgR, HER2 and grade), intrinsic subtype, pathological response (pCR or RD), and recurrence data. The patients were ordered according to correlation coefficients for the TP53 mutant signature. The color legends are shown in the figure. ER indicates estrogen receptor; HER2, human epidermal growth factor receptor type 2; pCR, pathological complete response; PgR, progesterone receptor; RD, residual disease.